Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Are there any male-to-female disparities in recurrence rates after surgery for Pilonidal Disease? A meta-analysis comparing differing mixed-gender cohorts].

Khirurgiia·2026
Same author

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

Blood cancer journal·2025
Same author

Gender-specific outcomes in pilonidal sinus disease: Female outcomes after cleft lift surgery in a large prospective Danish cohort.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2025
Same author

Long-term outcomes after cleft lift surgery for pilonidal sinus disease in post-pubertal adolescents: data from a prospective Danish cohort.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2024
Same author

The new small-angle X-ray scattering beamline for materials research at PETRA III: SAXSMAT beamline P62.

Journal of synchrotron radiation·2023
Same author

Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).

ESMO open·2023

Related Experiment Video

Updated: Jun 21, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Thromboprophylaxis--key points for the angiologist.

R M Bauersachs1, S Haas

  • 1Medizinische Klinik IV, Max Ratschow-Klinik für Angiologie, Klinikum Darmstadt, Darmstadt, Germany. Rupert.Bauersachs@klinikum-darmstadt.de

VASA. Zeitschrift Fur Gefasskrankheiten
|July 10, 2009
PubMed
Summary

Vascular specialists play a crucial role in managing venous thromboembolism (VTE) through diagnosis, treatment, and thromboprophylaxis. They must understand risk factors and appropriate preventative measures for patient safety.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Experiment Videos

Last Updated: Jun 21, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Area of Science:

  • Vascular Medicine
  • Thrombosis Management
  • Preventive Cardiology

Background:

  • Venous thromboembolism (VTE) poses a significant threat, particularly in hospitalized patients, representing a leading cause of preventable death.
  • Vascular specialists are essential for the accurate diagnosis, effective treatment, and crucial prevention of VTE.
  • Knowledge of VTE risk factors, patient risk stratification, and appropriate thromboprophylaxis strategies is vital for these specialists.

Purpose of the Study:

  • To underscore the indispensable role of vascular specialists in managing venous thromboembolism (VTE).
  • To emphasize the necessity for vascular specialists to possess comprehensive knowledge of VTE risk factors, risk groups, and thromboprophylaxis.
  • To highlight the importance of understanding pharmacological agents and their safe application in VTE prevention and treatment.

Main Methods:

  • Review of current guidelines and evidence regarding VTE prophylaxis.
  • Analysis of the role of pharmacological agents in VTE prevention.
  • Emphasis on risk-benefit assessment for individualized thromboprophylaxis strategies.

Main Results:

  • Vascular specialists require deep knowledge of VTE risk factors and patient stratification.
  • Familiarity with various pharmacological prophylactic strategies, including oral anticoagulants, is essential.
  • Routine pharmacological prophylaxis is not recommended for low-risk VTE patients; individualized assessment is key.
  • Prolonged thromboprophylaxis (4 weeks) is recommended for high-risk patients post-orthopedic or cancer surgery.

Conclusions:

  • Vascular specialists are central to improving patient safety by implementing effective thromboprophylaxis.
  • Adequate knowledge and application of thromboprophylaxis by vascular specialists can significantly reduce VTE-related mortality.
  • Individualized risk assessment and tailored prophylaxis are critical for optimal VTE management.